Clinical Trials Logo

Clinical Trial Summary

The aim of the present study was to compare hemoglobin (Hb) levels determined by point of care testing HemaCue and arterial blood gas analyzer with an automated hematology analyzer in critically ill geriatric patients.Forty geriatric patients requiring intensive care treatment were included in the study. Arterial blood sample was analyzed using HemaCue (HbHemaCueArterial), blood gas analyzer (Techno Medica, Gastat1800 series) (HbBGA) and an automated hematology analyzer (Cell Dyne 3700 System, Abbot Laboratories)(HbLab) as a reference method. Capillary blood measurements were performed (HbHemaCueCapillary) by HemaCue at bedside.


Clinical Trial Description

The aim of the present study was to compare hemoglobin (Hb) levels determined by point of care testing HemaCue and arterial blood gas analyzer with an automated hematology analyzer in critically ill geriatric patients.Forty geriatric patients requiring intensive care treatment were included in the study. Arterial blood sample was analyzed using HemaCue (HbHemaCueArterial), blood gas analyzer (Techno Medica, Gastat1800 series) (HbBGA) and an automated hematology analyzer (Cell Dyne 3700 System, Abbot Laboratories)(HbLab) as a reference method. Capillary blood measurements were performed (HbHemaCueCapillary) by HemaCue at bedside. Bland Altman Analysis was applied to the results . ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03509987
Study type Interventional
Source Kecioren Education and Training Hospital
Contact
Status Completed
Phase N/A
Start date March 1, 2018
Completion date April 5, 2018

See also
  Status Clinical Trial Phase
Completed NCT03242525 - Examination of the Time Advantage Between POCT and Conventional Central Laboratory Analysis
Completed NCT02449226 - Accuracy of Point-of-Care Measurement With the RapidPoint 500 Blood Gas Analyser N/A
Recruiting NCT05322395 - Pragmatic Randomised Trial of the ESC 0/1 Versus 0/3 Hour Troponin Pathway N/A